ISAL 2019 | Investigating relapse after allo-SCT in AML

Name: Investigating relapse after allo-SCT in AML
Uploaded: 2019-03-01T15:50:59.000Z
Duration: 2 min 50 s
Description: The cause of relapse in acute myeloid leukemia (AML) following allogeneic stem cell transplant is unknown, with many theories under investigation. John DiPersio, MD, PhD, of Washington University School of Medicine, Washington, WA, discusses our current understanding of this event from the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany, with a major focus on CT2A.

John DiPersio • 1 Mar 2019

ISAL 2019

Acute Myeloid Leukemia Leukemia

The cause of relapse in acute myeloid leukemia (AML) following allogeneic stem cell transplant is unknown, with many theories under investigation. John DiPersio, MD, PhD, of Washington University School of Medicine, Washington, WA, discusses our current understanding of this event from the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany, with a major focus on CT2A.